U
TTHI

UBS’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

UBS’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,538
Closed -$24K – 11456
2014
Q2 		$24K Buy
+3,538
New +$20.5K ﹤0.01% 7881
2013
Q4 		– Sell
-2,171
Closed -$9K – 11473
2013
Q3 		$9K Buy
2,171
+811
+60% +$3.19K ﹤0.01% 8985
2013
Q2 		$4K Buy
+1,360
New +$3.86K ﹤0.01% 9558

Other funds holding TTHI

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VC
Vestor Capital Chicago, Illinois $1.38B AUM 39.2% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
NC
NBW Capital Boston, Massachusetts $464M AUM 21.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

UBS's TTHI Position: Q3 2014 in Review

UBS sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2014, closing a stake of 3,538 shares — an estimated $24K sold.

UBS first reported a position in TTHI in Q2 2013 and held it in 3 quarters. The position peaked at $24K in Q2 2014. 17 funds tracked by Wall St. Rank hold TTHI as of Q3 2014.

  • UBS reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2014 after selling out during the quarter.
  • UBS sold 3,538 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2014, an estimated $24K.
  • UBS first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2013 and held it in 3 quarters.
  • UBS's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $24K in Q2 2014.
  • 17 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.